Drug Trial Radar · NCT03097107
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL
Last checked: Nov 20, 2026Latest source record: Feb 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
124
Planned (sponsor's estimate)
Start
Apr 6, 2017
Primary completion
Dec 2023
Study completion Jan 2024
Sponsor
- Lead sponsor
- Zydus Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 31, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of Saroglitazar Magnesium 1, 2, and 4 mg in patients with fasting triglyceride ≥500 mg/dL and ≤1500 mg/dL.
Conditions
- Dyslipidemias
Interventions
Saroglitazar Magnesium 1 mgDrug
Randomly assigned patients will receive saroglitazar magnesium 1 mg orally once each morning before breakfast for 12 weeks
Saroglitazar Magnesium 2 mgDrug
Randomly assigned patients will receive saroglitazar magnesium 2 mg orally once each morning before breakfast for 12 weeks
Saroglitazar Magnesium 4 mgDrug
Randomly assigned patients will receive saroglitazar magnesium 4 mg orally once each morning before breakfast for 12 weeks
PlaceboDrug
Randomly assigned patients will receive placebo orally once each morning before breakfast for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change in triglyceride cholesterol levelsTime frame: 12 Weeks
Locations
33 sites in 1 country. Site status is shown where the registry gives one.
Medical Affiliated Research Center, Inc.
Huntsville, Alabama
Encompass Clinical Research
Encinitas, California
Integrated Research Center
San Diego, California
Ventura Clinical Trials
Ventura, California
Colorado Springs Health Partners
Colorado Springs, Colorado
Meridien Research - Bradenton
Bradenton, Florida
Meridien Research - Lakeland
Lakeland, Florida
Oviedo Medical Research, LLC
Oviedo, Florida
Meridien Research - Tampa
Tampa, Florida
River Birch Research Alliance LLC
Blue Ridge, Georgia
Drug Studies America
Marietta, Georgia
Herman Clinical Research, LLC
Suwanee, Georgia
Cedar-Crosse Research Center
Chicago, Illinois
Heartland Research Associates, LLC
Newton, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
University of Maryland Medical Center
Baltimore, Maryland
Centennial Medical Group
Elkridge, Maryland
MD Medical Research
Oxon Hill, Maryland
Mercury Street Medical
Butte, Montana
Einstein Clinical Research
Charlotte, North Carolina
Triad Clinical Trials LLC
Greensboro, North Carolina
PMG Research of Wilmington, LLC
Wilmington, North Carolina
Metabolic and Atherosclerosis Research Center
Cincinnati, Ohio
Sterling Research Group, Ltd.
Cincinnati, Ohio
Wells Institute for Health Awareness
Kettering, Ohio
Ohio Clinical Research - Lyndhurst
Lyndhurst, Ohio
Awasty Research Network, LLC
Marion, Ohio
Ohio Clinical Research, LLC - Willoughby Hills
Willoughby Hills, Ohio
Columbia Research Group, Inc.
Portland, Oregon
PMG Research of Bristol, LLC
Bristol, Tennessee
Jackson Clinic
Jackson, Tennessee
Pioneer Research Solutions Inc.
Houston, Texas
National Clinical Research - Richmond, Inc
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.